Genespire Reports Durable Preclinical Gene Therapy Results for Methylmalonic Acidemia
MILAN, Italy, July 8, 2026 Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MILAN, Italy, July 8, 2026 Genespire, in collaboration with researchers at the San Raffaele Telethon Institute for Gene Therapy...
RANCHO CORDOVA, Calif., June 23, 2026 SK pharmteco has introduced SKyvecâ„¢, a next-generation multimodal viral vector platform designed to...
Philadelphia, September 25, 2025 – Verismo Therapeutics, a clinical-stage biotechnology company specializing in KIR-CAR T cell therapies, has announced...
